Targeted Delivery Methods for Anticancer Drugs
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Several drug-delivery systems have been reported on and often successfully applied in cancer therapy. Cell-targeted delivery can reduce the overall toxicity of cytotoxic drugs and increase their effectiveness and selectivity. Besides traditional liposomal and micellar formulations, various nanocarrier systems have recently become the focus of developmental interest. This review discusses the preparation and targeting techniques as well as the properties of several liposome-, micelle-, solid-lipid nanoparticle-, dendrimer-, gold-, and magnetic-nanoparticle-based delivery systems. Approaches for targeted drug delivery and systems for drug release under a range of stimuli are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Introduction and General Overview of Cyclodextrin Chemistry
Szejtli, J. (1998) · Chemical Reviews · doi:10.1021/cr970022c · Cited by 5,016
Diffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664 · cited 1×
“The thin-layer hydration method, also known as the Bangham method, is one of the first and still most commonly used methods for the preparation of liposomes [30].”
MethodGlutathione Metabolism and Its Implications for Health
Wu, G., Lupton, J. R., Turner, N. D., Fang, Y.-Z., & Yang, S. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.3.489 · Cited by 3,842
Micellar Nanocarriers: Pharmaceutical Perspectives
Torchilin, V. P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9132-0 · Cited by 1,910 · cited 1×
“In recent years, amphiphilic block copolymers, which spontaneously form micellar structures, have attracted much attention because of their use in the delivery of cytostatic drugs [38,39].”
BackgroundThe structure, function, and biosynthesis of plant cell wall pectic polysaccharides
Caffall, K. H., & Mohnen, D. (2009) · Carbohydrate Research · doi:10.1016/j.carres.2009.05.021 · Cited by 1,645
Thermosensitive sol-gel reversible hydrogels
Jeong, B., Kim, S. W., & Bae, Y. H. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00242-3 · Cited by 1,478
Danhier, F. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.015 · Cited by 1,288
Wu, J. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11080771 · Cited by 1,030 · cited 1×
“In addition to the traditional explanation, other theories concerning how the pathophysiological characteristics of tumor growth shape the EPR effect have been put forward [21,22].”
BackgroundAntibody–Drug Conjugates: An Emerging Concept in Cancer Therapy
Chari, R. V. J., Miller, M. L., & Widdison, W. C. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201307628 · Cited by 930
Shi, Y., van der Meel, R., Chen, X., & Lammers, T. (2020) · Theranostics · doi:10.7150/thno.49577 · Cited by 868
Wang, F., Wang, Y.-C., Dou, S., Xiong, M.-H., Sun, T.-M., & Wang, J. (2011) · ACS Nano · doi:10.1021/nn200007z · Cited by 813
The transferrin receptor and the targeted delivery of therapeutic agents against cancer
Daniels, T. R., Bernabeu, E., Rodríguez, J. A., Patel, S., Kozman, M., Chiappetta, D. A., Holler, E., Ljubimova, J. Y., Helguera, G., & Penichet, M. L. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.07.016 · Cited by 807
Enzyme-responsive nanoparticles for drug release and diagnostics
de la Rica, R., Aili, D., & Stevens, M. M. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.01.002 · Cited by 765
Fang, J., Islam, W., & Maeda, H. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.005 · Cited by 757 · cited 1×
“In addition to the traditional explanation, other theories concerning how the pathophysiological characteristics of tumor growth shape the EPR effect have been put forward [21,22].”
BackgroundRecent Advances in Tumor Targeting via EPR Effect for Cancer Treatment
Subhan, M. A., Yalamarty, S. S. K., Filipczak, N., Parveen, F., & Torchilin, V. P. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11060571 · Cited by 623 · cited 1×
“At the same time, it is important to note that the current understanding of the EPR effect is based on results obtained in animal models, meaning that the results of EPR-effect studies in patients must be collated if delivery systems that fully exploit the EPR effect are to be successfully designed [26].”
ResultRedox-responsive polymers for drug delivery: from molecular design to applications
Huo, M., Yuan, J., Tao, L., & Wei, Y. (2014) · Polym. Chem. · doi:10.1039/c3py01192e · Cited by 561
Drug targeting using thermally responsive polymers and local hyperthermia
Meyer, D. E., Shin, B. C., Kong, G. A., Dewhirst, M. W., & Chilkoti, A. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00319-4 · Cited by 416
Kwon, G., Suwa, S., Yokoyama, M., Okano, T., Sakurai, Y., & Kataoka, K. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90118-x · Cited by 409 · cited 1×
“Micelles that contain functional groups (-NH2, -COOH) in their core can transfer drugs by chemical modification and not just by physical encapsulation [41], and various cytostatic drug micelles (doxorubicin, paclitaxel) have shown significant results in several in-vitro and in-vivo studies [42].”
BackgroundInteractive Association of Drugs Binding to Human Serum Albumin
Yang, F., Zhang, Y., & Liang, H. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15033580 · Cited by 376
Micelles structure development as a strategy to improve smart cancer therapy
Hanafy, N., El-Kemary, M., & Leporatti, S. (2018) · Cancers · doi:10.3390/cancers10070238 · Cited by 287 · cited 1×
“Micelles that contain functional groups (-NH2, -COOH) in their core can transfer drugs by chemical modification and not just by physical encapsulation [41], and various cytostatic drug micelles (doxorubicin, paclitaxel) have shown significant results in several in-vitro and in-vivo studies [42].”
BackgroundCritical Review on Zeolite Clinoptilolite Safety and Medical Applications in vivo
Kraljević Pavelić, S., Simović Medica, J., Gumbarević, D., Filošević, A., Pržulj, N., & Pavelić, K. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01350 · Cited by 247
Pectin Matrix as Oral Drug Delivery Vehicle for Colon Cancer Treatment
Wong, T. W., Colombo, G., & Sonvico, F. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-010-9564-z · Cited by 210
Anti-cancer activities of pH- or heat-modified pectin
Leclere, L., Cutsem, P. V., & Michiels, C. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00128 · Cited by 203
Huang, D., Sun, L., Huang, L., & Chen, Y. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11020124 · Cited by 176 · cited 1×
“Traditionally, the EPR concept presumes that small molecules enter via diffusion and leave the interstitial space of the tumor, whereas macromolecules (containers, carriers) are no longer able to do so after extravasation [20].”
BackgroundPharmacokinetic and pharmacodynamic considerations in the development of therapeutic proteins
Mahmood, I., & Green, M. D. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544040-00001 · Cited by 150 · cited 1×
“To ensure targeted delivery, PEG is also often covalently bound to proteins (transport, signaling) so that, while the mechanism of action of the proteins does not change, there is a change in protein pharmacokinetics; PEG-asparaginase (used in the treatment of leukemia), PEG-aldesleukin (an antineoplastic agent), PEG-…”
Background
Cited by
PEGylated PLGA nanoparticles: unlocking advanced strategies for cancer therapy
Kesharwani, P., Kumar, V., Goh, K. W., Gupta, G., Alsayari, A., Wahab, S., & Sahebkar, A. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02410-x · Cited by 132
“A wide range of anticancer drugs have cytotoxic capabilities against both malignant and non-malignant cells [1–7].”
Cell Therapy as Target Therapy against Colon Cancer Stem Cells
Garza Treviño, E. N., Quiroz Reyes, A. G., Rojas Murillo, J. A., de la Garza Kalife, D. A., Delgado Gonzalez, P., Islas, J. F., Estrada Rodriguez, A. E., & Gonzalez Villarreal, C. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098163 · Cited by 24
Metadata
- Authors
- Veselov, V. V., Nosyrev, A. E., Jicsinszky, L., Alyautdin, R. N., & Cravotto, G.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2022-01-26
- Volume
- 14
- Issue
- 3
- Pages
- 622
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W4210625950
- Cited by
- 174
- References
- 26
- FWCI
- 7.39
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.